Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
But the question is: How do you do it
Periods of exclusivity for pharmaceutical products end as part of their normal life cycle, and generic treatments may become available over time. The company confirmed that semaglutides regulatory exclusivity in Canada will end in 2026, paving the way for competition in one of the drugs largest global markets.
Semaglutide is the active ingredient in Novo Nordisk's blockbuster weight loss drug Wegovy and diabetes treatment Ozempic
We advise our patients to reduce these
US$ 24.84
US$ 25.90
US$ 25.98
US$ 20.56
US$ 23.00
US$ 27.81
